Altium Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-41,485	Closed	-$4.23M	–	80
2023 Q2	$4.23M	Buy	41,485 +6,485	+19%	+$661K	3.2%	11
2023 Q1	$3.18M	Buy	+35,000	New	+$3.18M	1.77%	19